TXMD - TherapeuticsMD Inc. (TXMD) CEO Robert Finizio on Q2 2020 Results - Earnings Call Transcript
TherapeuticsMD, Inc. (TXMD)
Q2 2020 Earnings Conference Call
August 6, 2020 08:30 AM ET
Company Participants
Nichol Ochsner - Vice President of Investor Relations
Robert Finizio - Chief Executive Officer
James D’Arecca - Chief Financial Officer
Dawn Halkuff - Chief Commercial Officer
Mitch Krassan - Chief Strategy and Performance Officer
Conference Call Participants
Jen Kim - Cantor Fitzgerald
Stacy Ku - Cowen and Company
Douglas Tsao - H.C. Wainwright
Annabel Samimy - Stifel Financial Corp.
Presentation
Operator
Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD second quarter 2020 financial results